No.253 lymph node
Showing 1 - 25 of >10,000
Rectal Cancer Trial in Beijing, Shanghai, Chengdu (Dissection of the No.253 lymph node, Omitting the dissection of the No.253
Not yet recruiting
- Rectal Cancer
- Dissection of the No.253 lymph node
- Omitting the dissection of the No.253 lymph node
-
Beijing, Beijing, China
- +6 more
Nov 27, 2023
No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and
Recruiting
- Colorectal Cancer
- Lymph Node Metastasis
- Laparoscopic colorectal surgery
-
Beijing, Beijing, China
- +3 more
Nov 16, 2023
The Possible Range of No.12a Lymph Node Dissection of Locally
Recruiting
- Gastric Cancer
- No.12a Lymph Node Dissection
- The reasonable range of No.12a lymph node dissection
-
Tianjin, None Selected, ChinaDepartment of Gastric cancer, Tianjin Medical University Cancer
Sep 5, 2023
Fluorescence, Indocyanine Green, Rectal Cancer Surgery Trial in Beijing (Fluorescence laparoscopic system)
Recruiting
- Fluorescence
- +2 more
- Fluorescence laparoscopic system
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Sep 10, 2023
Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)
Recruiting
- Esophageal Squamous Cell Carcinoma
- no intervention
-
Wuhan, Hubei, ChinaRenmin hosptial of Wuhan University
Jul 29, 2023
Thyroid Cancer, Lymph Node Trial in Leon (US-guided fine needle aspiration (FNA))
Completed
- Thyroid Cancer
- Lymph Node
- US-guided fine needle aspiration (FNA)
-
Leon, Guanajuato, MexicoUnidad Medica de Alta Especialidad No. 1, Bajío
Nov 6, 2023
Lymph Node Metastasis Status in Cholangiocarcinoma Patients
Recruiting
- Cholangiocarcinoma
- No interventions.
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 1, 2023
Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
Recruiting
- Hilar Cholangiocarcinoma
- No interventions
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 16, 2022
Colorectal Tumor Trial in Shanghai
Recruiting
- Colorectal Neoplasm
-
Shanghai, Shanghai, ChinaRuijin hospital
Apr 15, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Two-Field lymph node dissection, Three-Field lymph node dissection)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Two-Field lymph node dissection
- Three-Field lymph node dissection
-
Shanghai, Shanghai, ChinaShanghai Zhongshan Hospital
Jun 15, 2022
Prostate Cancer Trial in Switzerland (Radical prostatectomy (RP) followed by ePLND, Radical prostatectomy (RP) only)
Active, not recruiting
- Prostate Cancer
- Radical prostatectomy (RP) followed by ePLND
- Radical prostatectomy (RP) only
-
Aarau, Switzerland
- +10 more
Feb 24, 2022
Breast Cancer Trial in Brazil (No axillary surgery, SLNB)
Recruiting
- Breast Cancer
- No axillary surgery
- SLNB
-
Fortaleza, CE, Brazil
- +13 more
Apr 6, 2022
Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)
Completed
- Breast Cancer
- anthracycline-based
- +3 more
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022
Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph
Recruiting
- Endometrial Cancer
- +8 more
- Laparoscopic hysterectomy with sentinel lymph node biopsy
-
Istra, Moscow Region, Russian FederationDepartment of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery Trial in Australia, Singapore (TH BSO with SNB Note: If participants
Recruiting
- Endometrial Cancer Stage I
- +2 more
- TH BSO with SNB Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
- TH BSO without retroperitoneal node dissection Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
-
Camperdown, New South Wales, Australia
- +12 more
Sep 7, 2022
Breast Cancer, Sentinel Lymph Node Trial in Seoul (No SLNB, SLNB)
Recruiting
- Breast Cancer
- Sentinel Lymph Node
- No SLNB
- SLNB
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 1, 2021
Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Radiation Therapy Boost
- +6 more
-
Washington, District of Columbia
- +8 more
Dec 5, 2022
Urinary Exosome lncRNAs for Preoperative Diagnosis of Lymphatic
Not yet recruiting
- Explore Whether lncRNA-ElNAT1 in Urine Exosomes Can be Used as a New Target for Preoperative Diagnosis of Lymph Node Metastasis
- no intervention
-
Guangzhou, ChinaSun Yat-sen Memorial Hosptial
Mar 6, 2022
Lung Tumors, Lymph Node Excision Trial in Tianjin (Systemic mediastinal lymph node dissection, No mediastinal lymph node
Not yet recruiting
- Lung Neoplasms
- Lymph Node Excision
- Systemic mediastinal lymph node dissection
- No mediastinal lymph node dissection
-
Tianjin, Tianjin, ChinaEthics review board of Tianjin Medical University Cancer Institu
Nov 15, 2020
Stomach Tumors Trial in Fuzhou (D2 lymphadenectomy including No. 10, D2 lymphadenectomy excluding No. 10)
Unknown status
- Stomach Neoplasms
- D2 lymphadenectomy including No. 10
- D2 lymphadenectomy excluding No. 10
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Sep 7, 2020
Colon Cancer Trial in Moscow (Left colon resection, Sigmoid colon resection, Distal sigmoid colon resection or anterior
Recruiting
- Colon Cancer
- Left colon resection
- +2 more
-
Moscow, Russian FederationClinic of coloproctology and minimally invasive surgery
Sep 29, 2021
Stomach Tumors Trial in Fuzhou (Robotic Assisted No.10 Lymph Node Dissections)
Completed
- Stomach Neoplasms
- Robotic Assisted No.10 Lymph Node Dissections
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Sep 7, 2020
Indocyanine Green, Gastric Cancer, Injection Site Trial in Fuzhou (Subserosa injection of indocyanine green, submucosal
Recruiting
- Indocyanine Green
- +2 more
- Subserosa injection of indocyanine green
- submucosal injection of indocyanine green
-
Fuzhou, Fujian, ChinaDepartment of Gastric Surgery
Mar 23, 2021
Cervical Cancer, Surgery, Quality of Life Trial in Guangzhou (no systematic pelvic lymphadenectomy)
Unknown status
- Cervical Cancer
- +2 more
- no systematic pelvic lymphadenectomy
-
Guangzhou, Guangdong, ChinaDepartment of Gynecologic Oncology, Sun Yat-sen University Cance
Jul 11, 2020
Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))
Not yet recruiting
- Carcinoma, Lobular
- [18F]fluoroestradiol (FES)
- (no location specified)
Jul 18, 2023